BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases. Immunol Rev 2019;291:174-89. [PMID: 31402499 DOI: 10.1111/imr.12791] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Langelier MJ, Vinh DC. Host-directed immunotherapy to fight infectious diseases. Curr Opin Pediatr 2022. [PMID: 36081357 DOI: 10.1097/MOP.0000000000001176] [Reference Citation Analysis]
2 Fournier B, Hoshino A, Bruneau J, Bachelet C, Fusaro M, Klifa R, Lévy R, Lenoir C, Soudais C, Picard C, Blanche S, Castelle M, Moshous D, Molina T, Defachelles AS, Neven B, Latour S. Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors. J Exp Med 2022;219:e20211682. [PMID: 35657354 DOI: 10.1084/jem.20211682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liang W, Li K, Zhang Q, Li K, Ai K, Zhang J, Jiao X, Li J, Wei X, Yang J. Interleukin-2 inducible T cell kinase (ITK) may participate in the anti-bacterial immune response of Nile tilapia via regulating T-cell activation. Fish Shellfish Immunol 2022:S1050-4648(22)00362-X. [PMID: 35779809 DOI: 10.1016/j.fsi.2022.06.044] [Reference Citation Analysis]
4 Costagliola G, Peroni DG, Consolini R. Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children. Front Pediatr 2022;10:855445. [PMID: 35757131 DOI: 10.3389/fped.2022.855445] [Reference Citation Analysis]
5 Constantinescu C, Petrushev B, Rus I, Stefanescu H, Frasinariu O, Margarit S, Dima D, Tomuleasa C. Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient following Therapy with Ixazomib-Lenalidomide-Dexamethasone. JPM 2022;12:678. [DOI: 10.3390/jpm12050678] [Reference Citation Analysis]
6 Cooke M, Kazanietz MG. Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity. Sci Signal 2022;15:eabo0264. [PMID: 35412850 DOI: 10.1126/scisignal.abo0264] [Reference Citation Analysis]
7 Leonardi L, Rivalta B, Leone F, Cancrini C, Caffarelli C, Marseglia GL, Cardinale F. Host Defenses to Viruses: Lessons from Inborn Errors of Immunity. Medicina 2022;58:248. [DOI: 10.3390/medicina58020248] [Reference Citation Analysis]
8 Münz C. Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection. Biomolecules 2022;12:38. [DOI: 10.3390/biom12010038] [Reference Citation Analysis]
9 Münz C. Modification of EBV-Associated Pathologies and Immune Control by Coinfections. Front Oncol 2021;11:756480. [PMID: 34778072 DOI: 10.3389/fonc.2021.756480] [Reference Citation Analysis]
10 Läderach F, Münz C. Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk. Microorganisms 2021;9:2191. [PMID: 34835317 DOI: 10.3390/microorganisms9112191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Lino CNR, Ghosh S. Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection. Cancers (Basel) 2021;13:4752. [PMID: 34638238 DOI: 10.3390/cancers13194752] [Reference Citation Analysis]
12 Rivalta B, Amodio D, Milito C, Chiriaco M, Di Cesare S, Giancotta C, Conti F, Santilli V, Pacillo L, Cifaldi C, Desimio MG, Doria M, Quinti I, De Vito R, Di Matteo G, Finocchi A, Palma P, Trizzino A, Tommasini A, Cancrini C. Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up. Front Pediatr 2021;9:703853. [PMID: 34540765 DOI: 10.3389/fped.2021.703853] [Reference Citation Analysis]
13 Liang JH, Wang C, Yiu SPT, Zhao B, Guo R, Gewurz BE. Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival. mBio 2021;12:e0153021. [PMID: 34281398 DOI: 10.1128/mBio.01530-21] [Reference Citation Analysis]
14 Pan B, Yang M, Wei X, Li W, Wang K, Yang M, Lu D, Wang R, Cen B, Xu X. Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma. Aging (Albany NY) 2021;13:18620-44. [PMID: 34282055 DOI: 10.18632/aging.203306] [Reference Citation Analysis]
15 El-Mallawany NK, Curry CV, Allen CE. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol 2021. [PMID: 34169507 DOI: 10.1111/bjh.17638] [Reference Citation Analysis]
16 Münz C. Immune Escape by Non-coding RNAs of the Epstein Barr Virus. Front Microbiol 2021;12:657387. [PMID: 34234755 DOI: 10.3389/fmicb.2021.657387] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Costagliola G, Consolini R. Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge. Clin Exp Immunol 2021;205:288-305. [PMID: 34008169 DOI: 10.1111/cei.13620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Münz C. Natural Killer Cell Responses during Human γ-Herpesvirus Infections. Vaccines (Basel) 2021;9:655. [PMID: 34203904 DOI: 10.3390/vaccines9060655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Dzobo K. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. OMICS 2021;25:358-71. [PMID: 34037476 DOI: 10.1089/omi.2021.0052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ku CL, Chen IT, Lai MZ. Infection-induced inflammation from specific inborn errors of immunity to COVID-19. FEBS J 2021;288:5021-41. [PMID: 33971084 DOI: 10.1111/febs.15961] [Reference Citation Analysis]
21 Fournier B, Latour S. Immunity to EBV as revealed by immunedeficiencies. Curr Opin Immunol 2021;72:107-15. [PMID: 33989894 DOI: 10.1016/j.coi.2021.04.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Caduff N, McHugh D, Rieble L, Forconi CS, Ong'echa JM, Oluoch PO, Raykova A, Murer A, Böni M, Zuppiger L, Schulz TF, Blackbourn DJ, Chijioke O, Moormann AM, Münz C. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection. Cell Rep 2021;35:109056. [PMID: 33951431 DOI: 10.1016/j.celrep.2021.109056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Deng Y, Chatterjee B, Zens K, Zdimerova H, Müller A, Schuhmachers P, Ligeon LA, Bongiovanni A, Capaul R, Zbinden A, Holler A, Stauss H, Hammerschmidt W, Münz C. CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion. Blood 2021;137:3225-36. [PMID: 33827115 DOI: 10.1182/blood.2020009482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ghosh S, Köstel Bal S, Edwards ESJ, Pillay B, Jiménez Heredia R, Erol Cipe F, Rao G, Salzer E, Zoghi S, Abolhassani H, Momen T, Gostick E, Price DA, Zhang Y, Oler AJ, Gonzaga-Jauregui C, Erman B, Metin A, Ilhan I, Haskologlu S, Islamoglu C, Baskin K, Ceylaner S, Yilmaz E, Unal E, Karakukcu M, Berghuis D, Cole T, Gupta AK, Hauck F, Kogler H, Hoepelman AIM, Baris S, Karakoc-Aydiner E, Ozen A, Kager L, Holzinger D, Paulussen M, Krüger R, Meisel R, Oommen PT, Morris E, Neven B, Worth A, van Montfrans J, Fraaij PLA, Choo S, Dogu F, Davies EG, Burns S, Dückers G, Becker RP, von Bernuth H, Latour S, Faraci M, Gattorno M, Su HC, Pan-Hammarström Q, Hammarström L, Lenardo MJ, Ma CS, Niehues T, Aghamohammadi A, Rezaei N, Ikinciogullari A, Tangye SG, Lankester AC, Boztug K. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood 2020;136:2638-55. [PMID: 32603431 DOI: 10.1182/blood.2020006738] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
25 Münz C. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses. Front Cell Infect Microbiol 2021;11:605258. [PMID: 33842383 DOI: 10.3389/fcimb.2021.605258] [Reference Citation Analysis]
26 Schuhmachers P, Münz C. Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice. Front Immunol 2021;12:640918. [PMID: 33833760 DOI: 10.3389/fimmu.2021.640918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Rispoli F, Valencic E, Girardelli M, Pin A, Tesser A, Piscianz E, Boz V, Faletra F, Severini GM, Taddio A, Tommasini A. Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies. Diagnostics (Basel) 2021;11:532. [PMID: 33809703 DOI: 10.3390/diagnostics11030532] [Reference Citation Analysis]
28 Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci 2021;22:2967. [PMID: 33803997 DOI: 10.3390/ijms22062967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Fournier B, Boutboul D, Bruneau J, Miot C, Boulanger C, Malphettes M, Pellier I, Dunogué B, Terrier B, Suarez F, Blanche S, Castelle M, Winter S, Delecluse HJ, Molina T, Picard C, Ehl S, Moshous D, Galicier L, Barlogis V, Fischer A, Neven B, Latour S. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. J Exp Med 2020;217:e20192262. [PMID: 32812031 DOI: 10.1084/jem.20192262] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
30 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
31 Houen G, Trier NH, Frederiksen JL. Epstein-Barr Virus and Multiple Sclerosis. Front Immunol 2020;11:587078. [PMID: 33391262 DOI: 10.3389/fimmu.2020.587078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Trottier AM, Godley LA. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities. Br J Haematol 2021;194:663-76. [PMID: 33615436 DOI: 10.1111/bjh.17247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Liu P, Pan X, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, Wu Y, Liu Y, Liu T. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Blood 2020;135:826-33. [PMID: 31914172 DOI: 10.1182/blood.2019003886] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
34 Münz C. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections. Front Immunol 2020;11:581419. [PMID: 33013936 DOI: 10.3389/fimmu.2020.581419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Münz C. Cytotoxicity in Epstein Barr virus specific immune control. Curr Opin Virol 2021;46:1-8. [PMID: 32771660 DOI: 10.1016/j.coviro.2020.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Krüger R, Martin E, Dmytrus J, Feiterna-Sperling C, Meisel C, Unterwalder N, Kölsch U, Wahn V, Hofmann J, Korn P, Latour S, Boztug K, von Bernuth H. CD70 Deficiency Associated With Chronic Epstein-Barr Virus Infection, Recurrent Airway Infections and Severe Gingivitis in a 24-Year-Old Woman. Front Immunol 2020;11:1593. [PMID: 32849540 DOI: 10.3389/fimmu.2020.01593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Le Voyer T, Boutboul D, Ledoux-Pilon A, de Fontbrune FS, Boursier G, Latour S, Le Guenno G. Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2. J Clin Immunol 2020;40:948-53. [PMID: 32643137 DOI: 10.1007/s10875-020-00812-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Münz C. Redirecting T Cells against Epstein-Barr Virus Infection and Associated Oncogenesis. Cells 2020;9:E1400. [PMID: 32512847 DOI: 10.3390/cells9061400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 2020;34:101515. [PMID: 32387063 DOI: 10.1016/j.berh.2020.101515] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
40 Rühl J, Leung CS, Münz C. Vaccination against the Epstein-Barr virus. Cell Mol Life Sci 2020;77:4315-24. [PMID: 32367191 DOI: 10.1007/s00018-020-03538-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
41 Jouanguy E. Human genetic basis of fulminant viral hepatitis. Hum Genet 2020;139:877-84. [PMID: 32285199 DOI: 10.1007/s00439-020-02166-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tangye SG. Genetic susceptibility to EBV infection: insights from inborn errors of immunity. Hum Genet 2020;139:885-901. [PMID: 32152698 DOI: 10.1007/s00439-020-02145-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
43 Münz C. Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice. Vaccines (Basel) 2019;7:E217. [PMID: 31861045 DOI: 10.3390/vaccines7040217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Münz C. The Role of Dendritic Cells in Immune Control and Vaccination against -Herpesviruses. Viruses 2019;11:E1125. [PMID: 31817510 DOI: 10.3390/v11121125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Luu K, Nickles E, Schwarz H. Destroy, what destroys you. Oncoimmunology 2020;9:1685301. [PMID: 32002301 DOI: 10.1080/2162402X.2019.1685301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]